Stryker Corp.'s biotech division and four current and former executives have been indicted on federal fraud charges related to their marketing of two bone-growth products.
Stryker Charged with Marketing FraudCourtesy MedPage Today Surgery Thu, 10/29/2009 - 12:49
Stryker Corp.'s biotech division and four current and former executives have been indicted on federal fraud charges related to their marketing of two bone-growth products. Popular products More related itemsNew study finds way to stop excessive bone growth...
Bone agent linked to problems in neck surgeries
Supplement Your Knowledge of Vitamin D
Pedifix Wart Stick Solid-stick Wart Remover Net...
Ride 'Em Cowgirl! Sex Position Secrets For Better...
|
Popular by tags Week
|
Post new comment